Work

Thiol-Activated Furoxan Nitric Oxide Donor–Tyrosine Kinase Inhibitor Hybrids Exploit NRF2-Dependent Redox Vulnerability in Triple-Negative Breast Cancer Cells

Cites:
Cited by:
Related to: 10